DrugDev to Speak about Site Payments and the Personal Value of Working in Clinical Research at the DIA 51st Annual Meeting

Share Article

Learn about the DrugDev Golden Number, preview upcoming technology innovations, and win $100 at exhibit booth #820.

DrugDev will guide important conversations regarding site payments and the personal value of working in clinical research

DrugDev wants to talk to clinical trial professionals attending the DIA 51st Annual Meeting in Washington D.C. from June 14-18 about how the industry can work together to help sponsors, CROs and sites do more trials. At DIA, DrugDev executives will guide important conversations regarding site payments and the personal value of working in clinical research in several key sessions. Visit DrugDev at exhibit booth #820 to learn about…

  •     The DrugDev Golden Number, a universal identifier for global sites and investigators used by the Investigator Databank and the forthcoming TransCelerate Investigator Registry
  •     The TrialNetworks study platform, a unified suite of apps to optimize workflow processes, site engagement and training
  •     DrugDev Payments, the industry’s leading specialized site payments provider with unrivaled international and VAT expertise
  •     DrugDev SiteStart, an efficient solution to identify and activate ideal sites leveraging a proprietary network of opted-in global investigators
  •     Upcoming technology innovations from the DrugDev Innovation Lab

DrugDev is proud to sponsor the Medical Heroes Appreciation 5K in support of the essential work being done by CISCRP, and the comany will be live Tweeting major developments from the conference - watch the Twitter hashtags #DoMoreTrials and #DIA2015 for breaking news and updates.

Visitors to the DrugDev exhibit booth will also have a chance to win a variety of prizes, including one of several $100 gift certificates, in a Golden Number raffle.

DrugDev presentations at DIA:

June 16, 3:30pm, Room 103B, Level One South - “Incorporating a VAT Tax Strategy into Your Global Investigator Payment Plan,” with Chairperson Stewart Mackie, Vice President of Client Services, DrugDev Payments; Alex Cotopoulis, Senior Manager, US VAT Practice, Ernst & Young LLP; and, Nicole McElroy, Vendor Management Lead, Shire Pharmaceuticals.

June 17, 10:30am, Room 152B – “PowerUp! Presentation: Try Law then Leave It – Like I Did,” with Brett Kleger, Chief Commercial Officer, DrugDev.

June 18, 10:45am, Room 150 A, Level One North - “Just the Facts: A Model for Evaluating the ROI of Outsourcing Investigator Payments,” with Chairperson Stuart Thiede, President, DrugDev Payments; Darren Hart, Global Head of Development Operations at Principia Biopharma Inc. and, Nicole McElroy, Contracts Manager, Shire Pharmaceuticals.

In addition, DrugDev colleagues and clients will present the following talks:

June 17, 10:30am, Room 202B: Level Two South - “Potential ROIs of eConsent: Patient Enrollment, Engagement, Retention and Compliance,” Eric Delente MA, CEO & Managing Director, Enforme and member of the DrugDev Innovation Lab.                                                        

June 17, 10:30am, Room 101, Level One South - “Can Investigator Crowdsourcing Be Used to Provide Insight into Compound Development?” Elise Felicione MBA, MPH, Director, Clinical Trial Innovation, Janssen Pharmaceutical Inc.

June 17, 1:30pm, Room 102AB, Level One South - “TransCelerate Collaboration: Harmonization Efforts to Find Solutions to Critical Industry Challenges,” with Andy Lee, MA, Senior Vice President, Head of Global Clinical Trial Operations Merck; Jacalyn Kent, Senior Director, Clinical Development Information & Optimization, Eli Lilly; Brett Wilson, Associate Director, Bristol-Myers Squibb Company, Canada; Edward Bowen, MBA, MS, Senior Director, Translational and Bioinformatics, Pfizer; and, Robert A. DiCicco, PharmD, Vice President, Clinical Pharmacology Sciences and Study Operations, GlaxoSmithKline

About DrugDev
DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com.

Connect with DrugDev on LinkedIn and Twitter.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Nashawaty
DrugDev
+1 617.688.3253
Email >
Visit website